文献速递痛风与晶体性关节病类风湿关节炎

孟德尔随机化-全表型关联研究:利用英国生物银行遗传工具探索血清尿酸水平对多种疾病结局的因果效应

MR-PheWAS: exploring the causal effect of SUA level on multiple disease outcomes by using genetic instruments in UK Biobank.
PubMed 文献 · Ann Rheum Dis · 2018-02-06

基于英国生物银行120 091人的数据,采用全表型关联研究(PheWAS)和孟德尔随机化(MR)分析血清尿酸(SUA)水平与多种疾病结局的因果关系。经多重检验校正后识别25个疾病组/结局与SUA遗传风险位点相关;常规MR提示SUA对炎症性多关节病、高血压病、代谢障碍、痛风、原发性高血压、心肌梗死和乳糜泻有因果作用;经MR Egger平衡多效性后,仅痛风及其所属炎症性多关节病组被认为与SUA水平存在因果关联。

要点

  • PheWAS识别25个疾病组/结局与SUA遗传风险位点相关(P<8.57e-05)。
  • 常规MR显示SUA对痛风(OR=4.88)和炎症性多关节病(OR=1.22)有因果作用。
  • MR Egger分析后仅痛风及炎症性多关节病组与SUA存在因果关联。

核心结论

  • SUA水平升高令人信服地导致痛风和炎症性多关节病,并可能作为更广泛相关疾病的标志物。
  • 研究结果支持进一步探究SUA水平与心血管、代谢、自身免疫和呼吸系统疾病的临床相关性。

研究设计与样本

  • 研究使用英国生物银行120 091名个体的数据。
  • 首先进行全表型关联研究(PheWAS)识别与SUA遗传风险位点相关的疾病结局。
  • 然后实施常规孟德尔随机化(MR)分析探究SUA水平与PheWAS识别出的疾病结局之间的因果关联。
  • 接着应用MR Egger分析检测并校正潜在多效性,并使用HEIDI检验去除可能由遗传连锁导致的跨表型关联。

主要发现

  • PheWAS在多重检验校正后(P<8.57e-05)识别出25个疾病组/结局与SUA遗传风险位点相关。
  • 常规MR分析提示SUA水平对三个疾病组有因果作用:炎症性多关节病(OR=1.22,95%CI 1.11至1.34)、高血压病(OR=1.08,95%CI 1.03至1.14)和代谢障碍(OR=1.07,95%CI 1.01至1.14)。
  • 常规MR分析还提示SUA水平对四个疾病结局有因果作用:痛风(OR=4.88,95%CI 3.91至6.09)、原发性高血压(OR=1.08,95%CI 1.03至1.14)、心肌梗死(OR=1.16,95%CI 1.03至1.30)和乳糜泻(OR=1.41,95%CI 1.05至1.89)。
  • 在MR Egger分析中平衡多效性效应后,仅痛风及其所属的炎症性多关节病组被认为与SUA水平存在因果关联。
  • 分析突出了一个位点(ATXN2/S2HB3),该位点可能通过多效性影响SUA水平和多种心血管及自身免疫疾病。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We aimed to investigate the role of serum uric acid (SUA) level in a broad spectrum of disease outcomes using data for 120 091 individuals from UK Biobank. METHODS: We performed a phenome-wide association study (PheWAS) to identify disease outcomes associated with SUA genetic risk loci. We then implemented conventional Mendelianrandomisation (MR) analysis to investigate the causal relevance between SUA level and disease outcomes identified from PheWAS. We next applied MR Egger analysis to detect and account for potential pleiotropy, which conventional MR analysis might mistake for causality, and used the HEIDI (heterogeneity in dependent instruments) test to remove cross-phenotype associations that were likely due to genetic linkage. RESULTS: Our PheWAS identified 25 disease groups/outcomes associated with SUA genetic risk loci after multiple testing correction (P<8.57e-05). Our conventional MR analysis implicated a causal role of SUA level in three disease groups: inflammatory polyarthropathies (OR=1.22, 95% CI 1.11 to 1.34), hypertensive disease (OR=1.08, 95% CI 1.03 to 1.14) and disorders of metabolism (OR=1.07, 95% CI 1.01 to 1.14); and four disease outcomes: gout (OR=4.88, 95% CI 3.91 to 6.09), essential hypertension (OR=1.08, 95% CI 1.03 to 1.14), myocardial infarction (OR=1.16, 95% CI 1.03 to 1.30) and coeliac disease (OR=1.41, 95% CI 1.05 to 1.89). After balancing pleiotropic effects in MR Egger analysis, only gout and its encompassing disease group of inflammatory polyarthropathies were considered to be causally associated with SUA level. Our analysis highlighted a locus (ATXN2/S2HB3) that may influence SUA level and multiple cardiovascular and autoimmune diseases via pleiotropy. CONCLUSIONS: Elevated SUA level is convincing to cause gout and inflammatory polyarthropathies, and might act as a marker for the wider range of diseases with which it associates. Our findings support further investigation on the clinical relevance of SUA level with cardiovascular, metabolic, autoimmune and respiratory diseases.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Li X, Meng X, Spiliopoulou A, et al. MR-PheWAS: exploring the causal effect of SUA level on multiple disease outcomes by using genetic instruments in UK Biobank. Ann Rheum Dis. 2018. PMID: 29437585. doi:10.1136/annrheumdis-2017-212534

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。